Table 2.
Preventive measures and legislation of Chagas disease in Europe.
| Country | Transmission risk | |
|---|---|---|
| Vertical | Blood transfusion/tissue or organ donation | |
| Spain | Systematic screening of pregnant women at risk only in the Valencian Community and Catalonia** | Screening of Latin Americans at risk and travellers (excluded for 6 months)* |
|
| ||
| France | No systematic screening | Screening of Latin Americans at risk and travellers (excluded for 4 months)* |
|
| ||
| Belgium | No systematic screening | Screening of Latin Americans at risk and travellers (Flemish Community) Exclusion of Latin Americans and temporarily of travellers (rest of the country) |
|
| ||
| United Kingdom | No systematic screening | Screening of Latin Americans at risk and travellers only in blood banks that dispose of the serological tests Exclusion in all other blood banks |
|
| ||
| Portugal | No systematic screening | Screening of donors at risk only in Lisbon |
|
| ||
| Italy | Systematic screening in Negrar, Bergamo, and Florence | Exclusion of donors with known Chagas disease and temporary exclusion of travellers (3 months) |
|
| ||
| Switzerland | Systematic screening in Geneva | Exclusion of donors with known Chagas disease |
|
| ||
| The Netherlands | No systematic screening | Exclusion of donors with known Chagas disease |
|
| ||
| Germany | No systematic screening | Exclusion of donors with known Chagas disease and temporary exclusion of travellers (6 months) |
|
| ||
| Austria | No systematic screening | No systematic screening |
|
| ||
| Luxembourg | No systematic screening | No systematic screening |
|
| ||
| Norway | No systematic screening | No systematic screening |
|
| ||
| Croatia | N.A. | N.A. |
|
| ||
| Denmark | N.A. | N.A. |
|
| ||
| Greece | N.A. | N.A. |
|
| ||
| Ireland | N.A. | N.A. |
|
| ||
| Romania | N.A. | N.A. |
|
| ||
| Sweden | N.A. | N.A. |
*National legislation, **regional legislation, N.A.: no information available.